Highlight
- The 10-2 visual field test does not significantly outperform the 24-2 test in detecting global or quadrant-level progression in early glaucoma.
- Pointwise analysis reveals the 10-2 test is more sensitive for detecting progression with steeper decline in central visual field points.
- Patients with worse baseline central vision defects on the 10-2 test benefit from monitoring with this test for early detection of faster progression.
Study Background
